11.11.2024 15:35:05
|
EQS-PVR: Formycon AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Formycon AG
Notification of Major Holdings
1. Details of issuer
2. Reason for notification
3. Details of person subject to the notification obligation
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
8. Information in relation to the person subject to the notification obligation
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
10. Other explanatory remarks: Date
11.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Formycon AG |
Fraunhoferstraße 15 | |
82152 Planegg-Martinsried | |
Germany | |
Internet: | www.formycon.com |
End of News | EQS News Service |
|
2027225 11.11.2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Formycon AGmehr Nachrichten
04.03.25 |
XETRA-Handel TecDAX am Dienstagmittag in der Verlustzone (finanzen.at) | |
04.03.25 |
XETRA-Handel SDAX im Minus (finanzen.at) | |
04.03.25 |
Angespannte Stimmung in Frankfurt: SDAX liegt zum Handelsstart im Minus (finanzen.at) | |
04.03.25 |
TecDAX aktuell: TecDAX zum Start des Dienstagshandels in Rot (finanzen.at) | |
03.03.25 |
Zuversicht in Frankfurt: TecDAX bewegt letztendlich im Plus (finanzen.at) | |
03.03.25 |
EQS-News: FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union (EQS Group) | |
03.03.25 |
EQS-News: Markteinführung von FYB202/Otulfi® (ustekinumab-aauz), einem Biosimilar zu Stelara® in den USA und der Europäischen Union (EQS Group) | |
03.03.25 |
TecDAX-Handel aktuell: TecDAX-Anleger greifen am Mittag zu (finanzen.at) |
Analysen zu Formycon AGmehr Analysen
04.03.25 | Formycon Buy | Hauck Aufhäuser Lampe Privatbank AG | |
24.02.25 | Formycon Buy | Warburg Research | |
20.02.25 | Formycon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.02.25 | Formycon Buy | Hauck Aufhäuser Lampe Privatbank AG | |
18.02.25 | Formycon Buy | Warburg Research |
Aktien in diesem Artikel
Formycon AG | 26,60 | 1,72% |
|